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Abstract
Background: Biobanking necessitates extensive integration of data to allow data analysis and specimen sharing.
Ontologies have been demonstrated to be a promising approach in fostering better semantic integration of
biobank-related data. Hitherto no ontology provided the coverage needed to capture a broad spectrum of
biobank user scenarios.
Methods: Based in the principles laid out by the Open Biological and Biomedical Ontologies Foundry two
biobanking ontologies have been developed. These two ontologies were merged using a modular approach
consistent with the initial development principles. The merging was facilitated by the fact that both ontologies use the
same Upper Ontology and re-use classes from a similar set of pre-existing ontologies.
Results: Based on the two previous ontologies the Ontology for Biobanking (http://purl.obolibrary.org/obo/obib.owl)
was created. Due to the fact that there was no overlap between the two source ontologies the coverage of
the resulting ontology is significantly larger than of the two source ontologies. The ontology is successfully
used in managing biobank information of the Penn Medicine BioBank.
Conclusions: Sharing development principles and Upper Ontologies facilitates subsequent merging of ontologies to
achieve a broader coverage.
Keywords: Ontologies, Biobanking, Biorepository, Terminology
Background
The field of biobanking demands data integration. This
need arises on multiple levels: institutional, cross-
institutional, and sometimes even cross-national. Most
institutions operate multiple biobanks that were estab-
lished to fulfill diverse user requirements and therefore
use different data representations and schemata. Inte-
grating the data from these biobanks is a challenge at
best and impossible at worst.
In recent years a number of projects have set out to
answer the call for more specimen and data sharing
across multiple biobanks and multiple institutions, both
on a national and on a transnational level [1, 2]. One of
the earliest examples of a transnational sample sharing
project is the European Biobanking and BioMolecular
Research Infrastructure (BBMRI) [3]. Using large amounts
of data from multiple biobanks is an important way to en-
able statistical analysis, which can lead to uncovering
associations between phenotypes and diseases [4]. The
two key challenges are a) identifying specimens for re-
search, and b) utilizing the existent wealth of information
present in biobanks effectively by integrating data stored
in those repositories [5, 6].
Andrade et al. have pointed out that semantically rich
ontologies provide a promising approach to integrating
data from diverse biobanks [7]. In 2013 Brochhausen et al.
published Ontologized MIABIS (OMIABIS), a Web
Ontology Language (OWL)-coded ontology for biobank
administration based on use cases and competency ques-
tions derived from BBMRI (http://purl.obolibrary.org/
obo/omiabis/merged/omiabis.owl) [8]. OMIABIS is one of
the source ontologies that was used in creating the Ontol-
ogy for Biobanking (OBIB). It is linked to the BBMRI ef-
fort [3] and is based on the Minimum Data Set for sharing
biobank samples, information and data [9]. One of the key
advantages of using ontologies, and in particular re-using
pre-existing ontological representations is the possibility
to link data from biobanks to other biological and bio-
medical repositories using common identifiers, e.g. from
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Gene Ontology [6]. This possibility will improve the utility
of the shared biobank data tremendously since it allows
easy retrieval of related data using semantic web technolo-
gies, such as RDF, SPARQL, and OWL. The capability to
use biobank data in that way will make biobanks even
more important for and accessible to translational re-
search since the data already exist in a way that allows
easy linkage to data across other disciplines from basic sci-
ence to clinical research.
In addition, the use of a formal logical model to repre-
sent aspects of biobanking procedures and protocols
prevents unnecessary complexity that can lead to cum-
bersome and error-prone data management and retrieval
processes. One example of a complexity issue is a biobank
protocol involving something as simple as specimen type.
Consider a blood collection protocol that collects two vials
of blood. Each vial contains an anti-coagulant, in this case
one is ethylenediaminetetraacetic acid (EDTA) and the
other monosodium citrate (NaCit). Each specimen goes
through centrifugation producing a number of plasma and
buffy coat specimens. The lab decides to tag their speci-
mens in the following way: "edta_plasma", "buffy_edta",
"nacit_plasma", "buffy_nacit". The "edta_plasma" and "buf-
fy_edta" specimens are the derivatives of the EDTA parent
specimen and analogously for "nacit_plasma" and "buffy_-
nacit" specimens. So the lab is encoding two pieces of in-
formation in the "specimen type", the parent specimen
and the anticoagulant. Notice also that they chose the
anticoagulant as the prefix for plasma specimens, but as
the suffix for the buffy specimens, due to their perception
that the anticoagulant is more important for the plasma
specimens and less so for the buffy specimens. Another
lab has a simpler protocol. They collect one EDTA speci-
men and produce plasma and buffy specimens. Since they
collect only one type of blood specimen, they tag their
specimens simply as "plasma" and "buffy". The information
about the anticoagulant is implied as is information about
the parent specimen. Imagine all these specimens end up
in a unified biobank. The following specimen types would
be present: edta_plasma, buffy_edta, nacit_plasma, buffy_-
nacit, plasma, and buffy. The inconsistencies are readily
apparent. An ontology can provide a formal model for
different attributes related to a specimen type, such as the
parent specimen and the anticoagulant. Based on these
attributes and others specimen types can be created as
axiomatically defined classes (Fig. 1).
In this paper we present and describe the Ontology for
Biobanking (OBIB). OBIB has been created by merging
OMIABIS with a more specimen-focused biobank ontol-
ogy developed at the University of Pennsylvania called
the Biobank Ontology (BO). We provide an overview of
the methodologies used to a) build both ontologies and
b) merge them. We also give an outline of the domain
covered by the newly created ontology and describe its
current use. Finally, we discuss the next steps in expand-
ing OBIB and linking it to ongoing efforts regarding bio-
bank terminology. While we think that shared ontologies
are one way to facilitate sharing information across
Fig. 1 Representation of edta_plasma, buffy_edta, nacit_plasma, buffy_nacit, plasma, and buffy specimens according to the OBIB strategy. Blue boxes
represent classes; red boxes represent individuals; red arrows represent rdfs:subClassOf; green arrows represent rdf:type; blue arrows represent OWL
object properties (the labels are specified). While all OWL object properties link instance to instance, in this figure there are object properties
connecting OWL classes to each other. This represents a property restriction on the source class with existential quantification (all-some restriction)
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multiple sites, the description and discussion of how to
technically implement such a system (federated queries)
are regarded as out of scope for this paper.
Methods
OBIB is the result of merging two pre-existing ontologies,
OMIABIS and BO. In this section we describe criteria and
methodologies used by both the developers of OMIABIS
and BO. We will give a brief overview over the two source
ontologies and describe the merging process in detail.
Both ontologies, OMIABIS and BO are built based on
the principles of the Open Biological and Biomedical
Ontologies (OBO) Foundry (http://obofoundry.github.io/
principles/fp-000-summary.html) [10]. Both are exten-
sions of the Ontology of Biomedical Investigations (OBI)
(http://purl.obofoundry.org/obo/obi.owl) [11]. OBI is
based on Basic Formal Ontology (BFO), an Upper
Ontology frequently used to represent biological and
biomedical domains [12, 13]. One of the OBO Foundry
principles is re-use of pre-existing ontologies or their
classes and object properties in order to prevent multiple
representations of the same entities. Both, OMIABIS and
BO re-use numerous terms from existing ontologies. Both
ontologies were developed based on a methodology that
focuses on representation of the real-world phenomena
that are described by the data, which is intended to be
managed, instead of creating OWL representations of
existing data schemata. Smith and Ceusters have coined
the term ontological realism for this approach [14]. The ex-
ample provided of specimen type shows that relying exclu-
sively on pre-existing data representations can lead to
problems integrating data from heterogeneous resources.
Instead of providing representations base on the term used,
such as "edta_plasma", "buffy_edta", "nacit_plasma", "buf-
fy_nacit", "plasma", and "buffy", ontologies should represent
the specimens, the parent specimens, the anticoagulants
and the different processes that were necessary to create
the specimen. Thus, individual specimens can be sorted
into specimen types based on what their parent specimens
are and which processes they passed through. This meth-
odological paradigm fosters linking the biological sources
to the specimens to the data about those specimens.
OMIABIS
Ontologized MIABIS (OMIABIS) (http://purl.obolibrary.
org/obo/omiabis/merged/omiabis.owl) was created as an
OWL implementation of the BBMRI's Minimum Informa-
tion About BIobank data Sharing (MIABIS). It is based on
the BBMRI use cases, which are mostly population and co-
hort based. Due to juridical and ethical reasons searching
individual specimens was out of scope for the initial imple-
mentation of OMIABIS [8].
The competency questions for the development of
OMIABIS were:
 Which biobanks hold frozen specimens?
 Which biobanks hold blood, plasma and serum?
 Which blood plasma specimens are owned by one
specific biobank organization?
 Which departments of a specific university have
members that are serving as biobank contacts?
 What are the e-mail addresses of all biobank contact
persons at one specific biobank organization?
These competency questions demonstrate that the
focus of the OMIABIS development was less to retrieve
information about individual specimens and to order
those specimens, but more to obtain basic population-
level and repository specific information about biobank
administration and related study administration. OMIA-
BIS represents both relevant objects, such as "biobank"
or "biobank organization", and relevant processes, such
as "specimen handling" and "sampling specimens for bio-
bank". Terms were re-used from the Cell Type Ontology
(CL), Chemical Entities of Biological Interest (ChEBI),
Common Anatomy Reference Ontology (CARO), Informa-
tion Artifact Ontology (IAO), NCBITaxonomy, Ontology
of Medically Relevant Social Entities (OMRSE), Phenotypic
Quality Ontology (PATO), Proper Name Ontology (PNO),
and Reagent Ontology (REO). One hundred twenty-six en-
tities were created specifically for OMIABIS resulting in a
total of 428 classes, 15 individuals, 75 object properties,
and 990 logical axioms. The ontology and additional details
can be found at https://github.com/OMIABIS/omiabis-dev.
Biobank ontology (BO)
Another biobank ontology based on OBI, BO, was gen-
erated independently of OMIABIS to address use cases
provided by the Penn Medicine BioBank, which served
along with OMIABIS as a starting point for OBIB. The
competency questions for the development of BO were:
 How many study subjects have filled out a patient
questionnaire for which there is an associated
collection packet?
 What blood specimens are available from study
participants? What chemical additive was used
in the container?
 What is the storage state of the specimen of
interest? How has the specimen been processed?
The BO aimed to address these competency questions
by covering the processes along with inputs and outputs
associated with a specimen in a biobank repository.
These included ‘human subject enrollment’ , ‘informed
consent process’ , ‘document editing’ (filling out case re-
port forms), ‘specimen collection process’ , ‘material pro-
cessing’ of the specimen, ‘storage’ of the specimen, and
shipping and handling processes. Patient-related terms
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(e.g., ‘smoking behavior’) were also included. Terms were
re-used from BFO, IAO, OBI, ChEBI, EFO, NCBITaxon,
OGMS, PATO, and UBERON. Approximately 50 terms
were added to address biobank specific needs (e.g., col-
lection packets for specimens) resulting in 227 classes,
18 individuals, 34 object properties, and 526 logical ax-
ioms. The ontology and additional details can be found
at https://github.com/biobanking/Penn-Biobank.
Methodology of merging OMIABIS and BO
The fact that both OMIABIS and BO were built based on
OBI and used BFO as top-level ontology greatly facili-
tated the integration of the two ontologies. However,
various BFO versions were used and some common
terms were included in both OMIABIS and BO. The fol-
lowing processes were performed before integration of
OMIABIS and BO:
1. Converted both ontologies using BFO version 2.0 Graz
release (http://purl.obolibrary.org/obo/bfo/2014-05-03/
classes-only.owl). The conversion was made using BFO
converter (http://bfoconvert.hegroup.org/).
2. Separated terms defined in OMIABIS or BO from
those defined in external resources (OBO Foundry
Ontologies) and saved those in different OWL files.
3. Identified terms defined in both OMIABIS and BO
and merged the overlapping terms where necessary.
This pre-processing of OMIABIS and BO before
merging resulted in the following files:
 omiabis.owl or biobank.owl: OMIABIS or BO
specific terms.
 import_OBI_subset.owl: OBI subset upon which
OMIABIS or BO was built containing terms needed
from both IAO and OBI. The OBI subset was
retrieved using Ontodog, a tool that can retrieve a
set of terms of interest and all related axioms from a
source ontology [15].
 import_OBO.owl: terms defined in external OBO
Foundry ontologies and retrieved using OntoFox, a
tool that can retrieve terms of interest from a source
ontology based on MIREOT mechanism [16].
 externalByhand.owl: terms defined in external OBO
Foundry ontologies added manually.
These files are available on the OMIABIS project
website:
OMIABIS: https://github.com/OMIABIS/omiabis-dev/
tree/master/BFO2%20omiabis and BO: https://github.
com/OMIABIS/omiabis-dev/tree/master/biobank-omiabis/
BFO2%20biobank.
Since OMIABIS and BO focused on different aspects
of biobanking, no overlap in terms was found between
OMIABIS and BO specific terms (omiabis.owl and
biobank.owl).
In preparing BO for merging it with OMIABIS, we
also compared BO to other OBO Foundry ontologies
relevant to the domain. We found a few BO terms re-
lated to informed consent that overlapped with terms
from the Informed Consent Ontology (ICO) [17]. These
BO terms were replaced by ICO terms. Since BO was
not officially registered as an OBO Foundry community,
BO specific terms were assigned OBIB term identifiers
after merging.
Protégé was used to perform the merging of the
OWL files prepared based on the two ontologies.
The process was a series of merges for pairs of
equivalent OWL files used by OMIABIS and BO to
create: import_OBI_subset.owl from subset OWL
files, import_OBO.owl from OWL files of external
terms retrieved using OntoFox [16], externalByhan-
d.owl from manually imported external terms OWL
files, and biobank-omiabis.owl from omiabis.owl and
biobank.owl. The one remaining BFO 1.1 class, Con-
nectedTemporalRegion, was dealt with by taking ad-
vantage of its definition as equivalent to the union
of its two subclasses, temporal_instant and tempora-
l_interval. These have both been mapped to BFO 2.0
classes, zero-dimensional temporal region and one-
dimensional temporal region, which were used to replace
ConnectedTemporalRegion.
These merged OWL files are available on github:
https://github.com/OMIABIS/omiabis-dev/tree/master/
biobank-omiabis.




Finally, the consistency of the merged ontology was
checked using Hermit 1.3.4 and no inconsistencies were
found.
Results
Ontology of biobanking (OBIB)
The first release of OBIB (http://purl.obolibrary.org/obo/
2014-09-22/obib.owl) was made based on the OWL files
described in section Methodology of merging OMIABIS
and BO. The development of OBIB followed the OBO
Foundry principles. OBIB is freely and openly available.
The latest release can be obtained from http://purl.
obolibrary.org/obo/obib.owl. The community driven
development is done using an open code repository,
https://github.com/biobanking/biobanking. Issues and
term requests can be communicated at https://github.
com/biobanking/biobanking/issues. Currently, OBIB con-
tains 516 classes including 126 OMIABIS and 46 OBIB
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classes, 19 individuals, 83 object properties, and 1172 lo-
gical axioms.
One of the central terms of OBIB is biobank. This term
was merged from OMIABIS. OBIB defines biobank as:
"A biobank is a collections of samples of biological
substances (e.g. tissue, blood, DNA) which are linked to
data about the samples and their donors. They have a
dual nature as collections of samples and data".
The equivalent class axiom, which provides a for-
mal machine-parsable definition, can be accessed at:
http://www.ontobee.org/ontology/OBIB?iri=http://purl.
obolibrary.org/obo/OMIABIS_0000000.
From these definitions it is obvious that from the per-
spective of OBIB, a biobank consists of both the speci-
mens and the data about the specimens and the specimen
collections. OBIB differentiates between a biobank and a
biobank organization. The latter is defined as:
"An organization bearing legal personality that owns or
administrates at least one biobank."
This differentiation enables concise representation of
an organization running more than one biobank, as is
regularly the case for hospitals, research facilities and
others. So, OBIB fills gaps regarding the representation
of biobanking that have so far existed in OBO Foundry
ontologies and other ontologies.
Due to the fact that OBIB is the result of merging two
independently developed ontologies, coverage is broad.
Naturally, it covers information about specimens and
processes like specimen collection, specimen handling
and storage. It also represents donors and patients and
medical record data pertaining to those. In addition, it
provides representation for clinical studies and specimens
and data accrued during those. In the current release, the
OBIB-generated terms are related to the containment of
the specimen (e.g., OBIB_0000028: collection packet), ad-
ditives (e.g. OBIB_0000022: blood additive role), and stor-
age mechanisms (e.g., OBIB_0000030: blood spot card).
OBIB specific terms were also generated for patient forms
(e.g., OBIB_0000017: data confirm questionnaire) and as-
sociated health-related questions (e.g., OBIB_0000053:
duration time of smoking).
Most terms needed by OBIB are not specific to bio-
banks and available from other OBO ontologies and
imported. Figure 2 shows a selection of the most rele-
vant classes of OBIB and their superclasses. The figure
shows that many classes in OBIB are re-used from other
commonly used ontologies of the biomedical domain,
such as OBI, IAO, and others, or subclasses of those
classes. Notably, some of those are central classes such
as "specimen" and "specimen collection", both re-used
Fig. 2 Selection of central classes of OBIB and their superclasses. The leftmost four BFO classes are subclasses of further BFO classes which are not
shown here for readability
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from OBI. Other OBI classes, such as "organization" and
"material maintenance" are superclasses for classes
highly relevant to the biobanking domain, such as "bio-
bank organization" and "specimen freezing".
This not only highlights the relevance of OBI for the
representations that are part of OBIB, but also provides
an important opportunity regarding the use of semantic
web technologies in translational research. Terms like
"specimen" are used by multiple ontologies. The National
Center for Biomedical Ontologies' (NCBO) BioPortal [18],
an ontology lookup service, retrieved 18 different repre-
sentations of the term "specimen" in BioPortal ontologies
(when queried Nov. 18, 2015). OBI's representation of
specimen is one of them. However, the only specimen rep-
resentations that are referred to by other ontologies are
the OBI representation (referenced by 11 other ontologies)
and the Semanticscience Integrated Ontology (SIO) [19]
representation (referenced by 1 other ontology). This
shows that the representation of specimen by OBI is by
far the one most widely used by other ontologies. Re-use
of OWL entities (such as "specimen") in multiple ontol-
ogies and in multiple applications using those ontologies
is relevant, since the representation comes with a Unique
Resource Identifier (URI) that allows linking data in RDF.
This is a key strategy of semantic web technology that
holds huge promise for the translational science commu-
nity. Data created for use in a specific domain (e.g. bio-
banking) can be linked easily with data created in another
domain (e.g. digital pathology) by using the same URIs to
refer to the same entities.
Usage of OBIB
At the Penn Medicine Biobank, OBIB is used as the
semantic framework for a search system that supports
cohort identification and deep data mining of the infor-
mation associated with biobank specimens and specimen
donors. We explored how OBIB could be used through
a specific competency question of case/control match-
ing. For cases, we wanted to identify patients who were
consented to the biobank, had a history of type 2 dia-
betes, took a particular statin medication on or before
the date of recruitment, and had a banked EDTA blood
specimen. Eligible controls needed to have type 2 dia-
betes, have no history of taking any statin medications,
and have a banked EDTA specimen. Controls needed to
be matched to cases by gender, age at the time of re-
cruitment, and Body-Mass Index (BMI). The end goal
was an integrated graph database that contained the in-
stances and semantics of our data and could be queried
to answer our competency question, one which exempli-
fied a typical request made about biobank data.
The data needed to answer the competency question
were located in several relational data sources. Diagnosis
and prescription data were stored in relational data
sources derived from the patients' electronic medical rec-
ord. Dates of birth and recruitment, gender, and BMI at
time of recruitment were gathered in case report forms
(CRF) at the time of enrollment. There were several itera-
tions of the CRFs that were stored in databases with differ-
ent table structures. A snapshot of the inventory data was
generated from the specimen inventory system.
The process of building an RDF search system to an-
swer our question was divided into 4 parts: 1) semantic
modeling, 2) data mapping and instantiation, 3) domain
knowledge linking, and 4) querying and testing (Fig. 3).
For semantic modeling, local domain experts and
OBO Foundry ontology experts generated an ontology
model using OBIB that included the portions of OBO
Foundry ontologies relevant to the data sources. In our
case this took the form of several Cmap [20] documents.
Each data source was mapped separately and encapsu-
lated the relational data, the semantics intrinsic in the
relational data and any relevant domain knowledge. An
additional model was created to show how the separate
data sources were related. This model served as a guide
to adding additional data sources and to the naming
convention of International Resource Identifiers shared
between data sources.
During data mapping and instantiation, the ontology
models were referenced to generate a concrete map of
how the relational data would be transformed into triples.
This mapping can be expressed in RDB to RDF Mapping
Language (R2RML) (http://www.w3.org/TR/r2rml), a lan-
guage developed by the World Wide Web Consortium.
There are several software conversion tools that use
R2RML to instantiate relational data as RDF triples. In
our case, we used D2RQ [21] as the conversion software
and a D2RQ specific mapping language that is a derivative
of R2RML.The ontology models were updated as neces-
sary while writing and testing the conversion files.
Domain knowledge linking involved loading the instan-
tiated RDF data and any related OBO ontologies into a
graph database. We used Stardog (http://www.stardog.
com) as our graph database into which we loaded RDF
instance data and OBIB.
Querying and testing involved verifying the instantiated
data were correct and answering the competency ques-
tion. Equivalent queries were generated against the rela-
tional and graph data to ensure the data were accurately
modeled.
Future work
Recent research has shown that in spite of aiming to foster
clear and concise class representation, definitions from on-
tologies do not always rate well with domain experts [22].
This highlights the need for closer collaboration between
ontology curators and domain terminology experts regard-
ing definitions, term descriptions and real life applicability.
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Therefore, the OBIB developers have started a collabor-
ation with domain experts heavily engaged in the area of
biobank terminology, the Duke Biobank, a consortium
organization within the Duke Translational Research Insti-
tute. The Duke Biobank led the effort to select and imple-
ment a commercial biospecimen information management
system (BIMS) to integrate information from Duke’s di-
verse biobanking entities. A priority at the outset of the
selection process was the establishment of the policy that
all biobanks participating in the BIMS must use a common
terminology. To that end, terms were identified and de-
fined through a consensus driven process with biobanking
domain experts across the Duke campus. Sources consid-
ered for terms included publications related to biobanking
terminology as well as related to biobanking pre-analytical
variables, existing data elements in use in the existing bio-
banks, a public comment period, and out-of-the-box terms
from the commercial BIMS, once it was purchased. The
18 month effort overall resulted in over 500 data elements
covering the lifecycle of the biospecimen, as defined by the
National Cancer Institute [23]. In an effort to further ex-
pand and share Duke’s work, a collaboration between
Duke and OBIB began in the fall of 2014. Currently the
collaboration is focused on the comparison of terms and
classes between the Duke terminology and OBIB in an
effort to identify intersections and gaps while implement-
ing OBIB classes, with the goal of extending OBIB to cover
the use cases underlying the development at Duke. To
date, this approach has resulted in two different outcomes:
i) A Duke term mapped exactly the OBIB term but the
naming was different (e.g. "collect" in Duke
terminology correspond to "specimen collection"
in OBIB).
ii) Duke term was not present in OBIB (e.g. Duke term
"sample set" and "sample family").
This led to the creation of new terms specifying
already existing classes in OBIB and highlighted the de-
mand for additional general classes in OBIB (e.g.,
OBI_0002080: human specimen set; OBI_0002077: spec-
imens derived from shared ancestor). The aim of this
close interaction between the additional ontology users
(Duke) and OBIB is to create a resource fulfilling the re-
quirements of heterogeneous users. The value of this
collaboration is in joining a robust biobanking termin-
ology developed for a specific institution’s use, with a
biobanking ontology created at two other institutions, le-
veraging domain knowledge in both biobanking and
ontology in order to establish a single, relevant ontology
Fig. 3 The process used for building the prototype RDF search system to answer the Penn Medicine Biobank case/control competency question.
1. Semantic Modeling-Ontology models are developed to model the semantics of the relational data and any OBO ontologies that are relevant
to the data sources and potential queries. 2. Data Mapping and Instantiation-The models developed in step 1 are used to write mapping files to
concretely map the relational data as RDF. Software tools to use these maps to instantiate the relational data as RDF data. 3. Domain Knowledge
Linking-The instantiated RDF data and any relevant OBO Foundry Ontologies are loaded into a graph database. 4. Querying and Testing-Queries
over the graph data can be created by referencing the OBIB model. To test, equivalent queries against the graph data and relational data are
constructed and run to ensure data correctness
Brochhausen et al. Journal of Biomedical Semantics  (2016) 7:23 Page 7 of 9
resource with broad coverage to be applied to the field
of biobanking.
Another key aspect of biobanking is related to in-
formed consent and retrieving information about the
consent given by the donors to facilitate research. We
have already pointed out that OBIB already contained a
basic representation of informed consent from the ICO.
However, in order to retrieve the actual content of the
consent it is not sufficient to limit the representation to
the consent documents and the consent process. It will
also be necessary to represent the rights and obligations
that are created through the consenting. We have begun
working with the developers of ICO to address this issue
in the context of biobanking. While the development of
an in depth representation of informed consent for bio-
banking is still ongoing, one strategy that has been iden-
tified as key, is using a pre-existing ontology that allows
the representation of rights and obligations and the
socio-legal processes that give rise to them. The funda-
mental aspects of this have already been addressed by
the Ontology of Document Acts (d-acts) (http://purl.
obofoundry.org/obo/iao/d-acts.owl) [24, 25].
Conclusion
We have seen that for domains as central as biobanking
more than one ontology might exist. In order to foster
semantic integration of data for the largest possible
number of users and consumers, it might be necessary
to merge two or more ontologies.
In this paper we demonstrated that merging ontologies
that share a common design methodology, and that ex-
tend the same Upper Ontology and Reference Ontology
can be done fairly easily and with consistency. Both
OMIABIS and BO adhere to OBO Foundry principles
and were created based on the methodological paradigm
of ontological realism. Both ontologies are extensions of
OBI, which is based on BFO.
We have also demonstrated how the result of the mer-
ger is currently used and allows answering competency
questions based on real-world use cases in the Penn
Medicine Biobank. Finally, we illustrated how OBIB can
serve as a means to capture the semantics and share the
value of terminologies developed for institutional biobanks.
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